Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

China Feature Special

- PMLiVE

Xtandi slowdown weighs on Pfizer, but CEO won’t move on M&A

Investors call on the pharma giant to consider a large merger or acquisition deal

AstraZeneca AZ

Clock starts ticking on FDA review of AZ’s acalabrutinib

If approved, the BTK inhibitor could achieve annual peak sales of $5bn

AstraZeneca AZ

AZ takes Chi-Med’s kidney cancer drug into phase III

SAVOIR trial will compare Chi-Med’s savolitinib to Pfizer’s Sutent

Digital disruption

How pharma is keeping up with the pace of change

AstraZeneca AZ

AZ trial adds to pessimism about anti-IL-13 asthma drugs

Firm's IL-13 inhibitor failed to reduce the number of asthma attacks compared to placebo

- PMLiVE

Healthcare transformation and innovation

The healthcare and technology revolution

- PMLiVE

Strong Tagrisso soothes AZ as US sales plummet

Sales decline 34% in the US due to low-cost copies of Crestor

Pfizer invests in Swedish digital health firm

AMRA's technology transforms MRI images into precise fat and muscle measurements 

Novo signs personalised digital health deal in diabetes

Will work with Glooko on jointly-developed and branded solutions

National Institute for Health and Care Excellence NICE logo

NICE recognises Smartinhaler as best practice for asthma care

Digital monitoring device proven to increase adherence and reduce hospital visits

Astellas launches digital health investment company

Will look for firms that focus on patient outcomes and offer pharma synergies

Merck’s accelerator to take start-ups to Silicon Valley

Will expand the reach of its Darmstadt and Nairobi programmes

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links